Mar 072016
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, CA – Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the appointment of Jim Daly to its board of directors. Mr. Daly is a biopharmaceutical executive with 30 years of experience leading U.S.… => more

Halozyme Therapeutics appoints Jim Daly to the Board of Directors

From:: Halozyme Therapeutics appoints Jim Daly to the Board of Directors

 Posted by at 2:00 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: